Pfizer acquires Metsera for $10 billion, cementing their new obesity treatment strategy. The purchase concludes a weeklong bidding frenzy between the New York-based pharmaceutical company and Danish heavyweight Novo Nordisk, whose last-minute counterbid was finally rejected by US antitrust regulators.According to Reuters, Metsera’s board accepted a higher offer from Pfizer…
The past week has been one of extraordinary developments across politics, markets, and technology. From a historic mayoral election…
Wall Street heads into the new week on edge after a volatile stretch that saw major indices slide from…
The Nasdaq 100 Index and its related ETFs, like QQQ and JEPQ plunged last week as concerns about technology…
The S&P 500 Index retreated sharply last week, moving from the year-to-date high of $6,915 to a low of…
The MSTR stock price has been in a strong downtrend, mirroring the performance of other Digital Asset Treasury (DAT)…
Tesla’s stock dipped on Friday morning, even after shareholders overwhelmingly approved CEO Elon Musk’s record-breaking $1 trillion compensation package.…
A top German general is sounding the alarm, warning that Russia could launch a limited strike on NATO territory…
Archer Aviation Inc (NYSE: ACHR) crashed roughly 20% this morning after announcing a $126 million acquisition of Hawthorne Airport…